Subject Area


Article Type

Original Study


Background: Cervicogenic headache (CGH) has been considered as a common type of headache all over the world. There are a lot of therapeutic modalities for Cervicogenic headache either non-invasive or invasive strategies. Based on the original cause of pain, there are several approaches of local or regional anesthesia injections comprising nerve root injections, trigger point blocks, peripheral nerve blocks, or facet blocks Aim: To assess the efficacy of the ultrasound (US)-guided greater occipital nerve (GON ) block in Cervicogenic headache . Methods: The study was designed as a prospective interventional study that included 50 patients with Cervicogenic headache after fulfillment of criteria according to ICHD-III Classification and treated by US-guided nerve block. As regard Anesthetic used, it consisted of one mL of 2% lidocaine, 2.5 mL of 0.25% Marcaine, and 1ml of betamethasone are injected Results: There was statistically significant decrease of numeric pain scale from 6.64 pre-treatment to 1.7 by(74.4%) after 30 minutes, then slight increase to 2.62 (60.5%) after 2 weeks and slight increase to 3.32(60.5%) after 4 weeks and then increase to 4 (39.8%)after 8 weeks. A statistically significant difference was detected for each follow up in comparison with pre-treatment value regarding physical functioning, emotional functioning score, emotional well-being, pain domain, general health domain and health change domain of quality of life (QoL) Conclusion: Ultrasound-guided greater occipital nerve block has been demonstrated to be novel, safe and effective treatment method which was associated with pain reduction (as revealed by numeric pain scale) and better QoL (as revealed by Rand-36).

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.